Watchman FLX Archives - Cardiovascular News

LAA closure device non-inferior to blood thinners in lowering stroke risk and death for some AF patients

30th March 2026

For patients with non...

AHA 2024: OPTION trial reports positive outcomes for Watchman FLX at three years after AF ablation

19th November 2024

Three-year results fr...

Medtech Insights: Trial pipeline underpins growth strategy for Watchman LAAC device

5th July 2024

Investment in a programme...

CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX

28th February 2022

Results from a new an...

Next-generation Watchman LAAC device gains US FDA approval

22nd July 2020

Boston Scientific has...

Boston Scientific announces schedule of presentations at TCT 2019

20th September 2019

Boston Scientific has...

New trial to compare Watchman FLX to direct oral anticoagulants

25th June 2019

The OPTION trial is t...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy